75 results on '"Pålsson, Erik"'
Search Results
2. Cohort Profile: The St. Göran Bipolar Project
3. Dissecting the impact of complement component 4A in bipolar disorder
4. Altered brain dopamine metabolism is a trait marker for bipolar disorder
5. Recent Secular Trends of Body Mass Index in Individuals With Bipolar Disorders and in the General Population
6. Cardiometabolic risk indicators in individuals with bipolar disorders: a replication study
7. Ghrelin activates the mesolimbic dopamine system via nitric oxide associated mechanisms in the ventral tegmental area
8. Cohort profile: the Swedish National Quality Register for bipolar disorder(BipoläR)
9. Alterations in the serum proteome following electroconvulsive therapy for a major depressive episode: a longitudinal multicenter study
10. Time effect on cardiometabolic risk indicators in patients with bipolar disorder: a longitudinal case–control study
11. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder
12. Association Between Polygenic Risk Scores and Outcome of ECT
13. T24. NOT ALL BIPOLAR DISORDER OUTCOMES ARE CREATED EQUAL: OCCUPATIONAL DYSFUNCTION AND HOSPITAL ADMISSIONS ASSOCIATE WITH DIFFERENT POLYGENIC LIABILITIES
14. Ghrelin activates the mesolimbic dopamine system via nitric oxide dependent mechanisms in the ventral tegmental area
15. Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study
16. A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
17. Metabolomics analysis of cerebrospinal fluid suggests citric acid cycle aberrations in bipolar disorder
18. TH21. CEREBROSPINAL FLUID PROTEOMICS TARGETED FOR CENTRAL NERVOUS SYSTEM PROCESSES IN BIPOLAR DISORDER
19. Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder
20. Serum profiling of anorexia nervosa: A 1H NMR-based metabolomics study
21. Long-term trajectory of cognitive performance in people with bipolar disorder and controls: 6-year longitudinal study
22. Regional lithium prescription rates and recurrence in bipolar disorder
23. Patient educational level and management of bipolar disorder
24. Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls
25. Central levels of tryptophan metabolites in subjects with bipolar disorder
26. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy
27. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
28. CACNA1C polymorphism and brain cortical structure in bipolar disorder
29. Genomic evaluation of circulating proteins for drug target characterisation and precision medicine
30. Long-term subjective memory after electroconvulsive therapy
31. Executive functioning but not IQ or illness severity predicts occupational status in bipolar disorder
32. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
33. Characteristics of bipolar I and II disorder: A study of 8766 individuals
34. Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
35. Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder
36. Psychoeducation for bipolar disorder and risk of recurrence and hospitalization – a within-individual analysis using registry data
37. Large-scale serum biomarker profiling in patients with bipolar disorder
38. Classification of cognitive performance in bipolar disorder
39. Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
40. Personality traits in bipolar disorder and influence on outcome
41. Genetic Influences On Inflammatory Biomarkers In Bipolar Disorder
42. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder
43. Polymorphisms of BDNF and CACNA1C are not associated with cognitive functioning in bipolar disorder or healthy controls
44. Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome
45. CACNA1Cpolymorphism and altered phosphorylation of tau in bipolar disorder
46. Polymorphisms of dopamine pathway genesNRG1andLMX1Aare associated with cognitive performance in bipolar disorder
47. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
48. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
49. Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
50. Increased brain nitric oxide levels following ethanol administration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.